TrialAnnals of oncology : official journal of the European Society for Medical Oncology2011

Which patients benefit most from adjuvant aromatase inhibitors? Results using a composite measure of prognostic risk in the BIG 1-98 randomized trial.

G Viale et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.